Spironolactone for Heart Failure

Unknown Phase 3 NCT04727073

Study Description

Evaluating the Effectiveness of Spironolactone in Treating Heart Failure with Preserved or Mid-Range Ejection Fraction

Study Details

Registry ID:
NCT04727073
Conditions:
Heart Failure with Mid-range Ejection Fraction, Heart Failure with Preserved Ejection Fraction
Phase:
Phase 3
Target Enrollment:
743 participants
Start Date:
Healthy Volunteers:
No

Study Locations (69 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →